Page last updated: 2024-08-26

bosentan anhydrous and Hepatitis C, Chronic

bosentan anhydrous has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eller, P; Fuschelberger, R; Grander, W; Tilg, H	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Hepatitis C, Chronic

Article	Year
Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C. European journal of clinical investigation, 2006, Volume: 36 Suppl 3 Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Sulfonamides; Treatment Outcome	2006

Article

Year

Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C.

European journal of clinical investigation, 2006, Volume: 36 Suppl 3

Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Sulfonamides; Treatment Outcome

2006